Methods: During a 2,5-year period, all patients receiving topiramate for migraine were evaluated after 3 months of treatment. The parameters evaluated were adherence to treatment, frequency in ...

Topiramate, an antiepileptic drug with potential ... has proven efficacy and tolerability in migraine. In a prospective open-label study, Lampl and co-workers have shown this drug to have promise ...

Doctors prescribe topiramate to adults and some children to: treat epilepsy help prevent migraine headaches Topiramate oral tablets are a generic medication that contains the active drug topiramate.

Topiramate has recently received a formal indication for migraine prevention or treatment but did not have such indication when the study was conducted. Storey and colleagues [16] randomized 40 ...

Topamax (topiramate) is a brand-name prescription drug used to prevent migraine attacks and treat epilepsy in certain people. Long-term side effects with Topamax are not common but can occur in ...

Topamax (topiramate) is an anticonvulsant or a drug used to treat seizures. It is also approved to prevent migraine headaches ...

That means patients will have to have tried three other oral preventive treatments, which could include topiramate ... NICE in February as an acute treatment for migraine in draft guidance ...

Topamax and Depakote are both FDA-approved to prevent certain types of seizures, as well as prevent migraine. The way anti-seizure drugs work to prevent migraine is not completely understood ...

In a clinical practice guideline (CPG) issued by the U.S. Department of Veterans Affairs and U.S. Department of Defense and published online Oct. 29 in the Anna ...

Eptinezumab was approved by the United States Food and Drug Administration (FDA) for preventive treatment of migraine in adults in February 2020. It has not been approved for any other indication ...

Topamax (topiramate) is a brand-name drug that a doctor or healthcare professional may prescribe off-label for weight loss. The drug is not approved for this use, but it has been shown to help ...

Novartis’ Aimovig (erenumab) has been approved by the European Medicines Agency (EMA) making it first self-administered, monthly migraine prevention jab available for adult patients in Europe.